🇺🇸 FDA
Patent

US 7452866

Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1

granted A61KA61K38/04A61K38/1709

Quick answer

US patent 7452866 (Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1) held by Alseres Pharmaceuticals, Inc. expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alseres Pharmaceuticals, Inc.
Grant date
Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/04, A61K38/1709